Future research and validation studies are crucial in elucidating the clinical significance of FABP4, both as a biomarker and as a therapeutic target for conditions such as diabetes and obesity, ultimately enhancing our ability to manage and address these pressing health concerns more effectively. Here, FABP4 is linked to obesity disorder.